CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $127,561
- in 3 filings, $17K under 10b5-1 plans
Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-01 | Crombez Eric EVP and Chief Medical Officer | Grant or award | +4,658 | 30,512 | ||
| 2023-05-01 | Crombez Eric EVP and Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +8,362 | 8,362 | ||
| 2023-04-16 | Huizenga Theodore Alan SVP, Chief Accounting Officer | Shares withheld for taxes | −14 | $38.20 | $535 | 27,701 |
| 2023-04-16 | Huizenga Theodore Alan SVP, Chief Accounting Officer | Returned to the company | −181 | $38.20 | $7K | 27,520 |
| 2023-03-01 | Bedrosian Camille L EVP and Chief Medical Officer | Grant or award | +2,663 | 50,601 | ||
| 2023-03-01 | Bedrosian Camille L EVP and Chief Medical Officer | Sale | −3,881 | $45.25 | $176K | 46,720 |
| 2023-03-01 | Parschauer Karah Herdman EVP and Chief Legal Officer | Grant or award | +2,663 | 37,101 | ||
| 2023-03-01 | Parschauer Karah Herdman EVP and Chief Legal Officer | Grant or award | +22,000 | 59,101 | ||
| 2023-03-01 | Parschauer Karah Herdman EVP and Chief Legal Officer | Sale | −3,161 | $45.25 | $143K | 56,139 |
| 2023-03-01 | Parschauer Karah Herdman EVP and Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +39,400 | 39,400 | ||
| 2023-03-01 | Kassberg Thomas Richard CBO & EVP | Grant or award | +2,663 | 230,222 | ||
| 2023-03-01 | Kassberg Thomas Richard CBO & EVP | Grant or award | +22,000 | 252,222 | ||
| 2023-03-01 | Kassberg Thomas Richard CBO & EVP | Sale | −1,968 | $45.27 | $89K | 250,254 |
| 2023-03-01 | Kassberg Thomas Richard CBO & EVP | Returned to the company | −3,394 | $45.65 | $155K | 246,860 |
| 2023-03-01 | Kassberg Thomas Richard CBO & EVP | Grant or award · Stock Option (Right to Buy) | +39,400 | 39,400 | ||
| 2023-03-01 | Huizenga Theodore Alan SVP, Chief Accounting Officer | Grant or award | +7,590 | 23,148 | ||
| 2023-03-01 | Huizenga Theodore Alan SVP, Chief Accounting Officer | Sale | −100 | $45.65 | $5K | 23,048 |
| 2023-03-01 | Huizenga Theodore Alan SVP, Chief Accounting Officer | Returned to the company | −1,333 | $45.65 | $61K | 21,715 |
| 2023-03-01 | Huizenga Theodore Alan SVP, Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +10,120 | 10,120 | ||
| 2023-03-01 | Huang Dennis Karl See Remarks | Grant or award | +2,663 | 53,703 |
Page 13 of 21 · 410 trades